Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 12/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 7/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13413670 | 0.86 | TSHR (0.47) | TSHREPHX1EPHX2ACHE | |
| SCHEMBL13413664 | 0.85 | TSHR (0.60) | TSHREPHX1 | |
| SCHEMBL1840972 | 0.78 | TSHR (0.62) | TSHREPHX1EPHX2ACHE | |
| SCHEMBL1953152 | 0.78 | TSHR (0.64) | TSHREPHX1ACHE | |
| SCHEMBL980008 | 0.78 | TSHR (0.64) | TSHREPHX1ACHE | |
| SCHEMBL1953272 | 0.78 | TSHR (0.64) | TSHREPHX1ACHE | |
| SCHEMBL1954247 | 0.78 | TSHR (0.64) | TSHREPHX1ACHE | |
| SCHEMBL983495 | 0.78 | TSHR (0.64) | TSHREPHX1ACHE | |
| SCHEMBL1840088 | 0.78 | TSHR (0.64) | TSHREPHX1ACHE | |
| SCHEMBL1024870 | 0.78 | TSHR (0.64) | TSHREPHX1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7674842-B2 | Phase change inks containing curable isocyanate-derived compounds and phase change inducing components | XEROX CORPORATION (US) | 2010-03-09 | — | — | US | disclosed |
| US-7674842-B2 | Phase change inks containing curable isocyanate-derived compounds and phase change inducing components | XEROX CORPORATION (US) | 2010-03-09 | — | — | US | disclosed |
| US-7541406-B2 | Phase change inks containing curable isocyanate-derived compounds | XEROX CORPORATION (US) | 2009-06-02 | — | — | US | disclosed |
| US-7541406-B2 | Phase change inks containing curable isocyanate-derived compounds | XEROX CORPORATION (US) | 2009-06-02 | — | — | US | disclosed |
| US-7449515-B2 | Phase change inks containing compounds derived from isocyanate, unsaturated alcohol, and polyol | XEROX CORPORATION (US) | 2008-11-11 | — | — | US | disclosed |
| US-7449515-B2 | Phase change inks containing compounds derived from isocyanate, unsaturated alcohol, and polyol | XEROX CORPORATION (US) | 2008-11-11 | — | — | US | disclosed |
| US-20070123642-A1 | Phase change inks containing curable isocyanate-derived compounds | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
| US-20070123642-A1 | Phase change inks containing curable isocyanate-derived compounds | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
| US-20070123641-A1 | Phase change inks containing compounds derived from isocyanate, unsaturated alcohol, and polyol | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
| US-20070123641-A1 | Phase change inks containing compounds derived from isocyanate, unsaturated alcohol, and polyol | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
| US-20070120909-A1 | Phase change inks containing curable isocyanate-derived compounds and phase change inducing components | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
| US-20070120909-A1 | Phase change inks containing curable isocyanate-derived compounds and phase change inducing components | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |